Cue Biopharma, Inc.
CUE
$0.84
$0.02182.66%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 99.05% | -39.94% | -27.86% | 7.96% | -26.81% |
Total Receivables | -- | -- | -70.02% | 70.66% | 31.93% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 24.80% | 133.91% | -52.20% | -16.80% | -9.64% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 93.61% | -36.63% | -32.53% | 9.90% | -24.11% |
|
|||||
Total Current Assets | 93.61% | -36.63% | -32.53% | 9.90% | -24.11% |
Net Property, Plant & Equipment | 35.51% | -15.06% | 5.15% | -15.94% | -13.43% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 94.08% | -0.05% | -25.02% | -0.07% | -0.10% |
Total Assets | 82.92% | -30.87% | -28.16% | 5.86% | -21.54% |
|
|||||
Total Accounts Payable | -4.15% | 34.04% | -56.39% | 65.75% | -0.33% |
Total Accrued Expenses | -64.11% | 45.46% | -9.10% | -29.88% | -12.40% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -34.81% | -11.74% | 14.80% | -2.24% | -2.20% |
Total Finance Division Other Current Liabilities | 1,690.47% | 529.41% | -67.18% | -73.46% | -45.47% |
Total Other Current Liabilities | 1,690.47% | 529.41% | -67.18% | -73.46% | -45.47% |
Total Current Liabilities | 24.24% | 13.21% | -18.47% | 2.01% | -9.02% |
|
|||||
Total Current Liabilities | 24.24% | 13.21% | -18.47% | 2.01% | -9.02% |
Long-Term Debt | -- | -- | -- | -41.91% | -29.53% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 1,663.64% | -82.45% | -24.36% | -32.42% | -23.92% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 43.86% | 6.68% | -24.44% | -6.10% | -13.41% |
|
|||||
Common Stock & APIC | 5.56% | 0.37% | 0.46% | 3.59% | 0.51% |
Retained Earnings | -2.40% | -3.59% | -2.86% | -2.68% | -3.24% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 175.97% | -62.40% | -31.01% | 17.32% | -28.02% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 175.97% | -62.40% | -31.01% | 17.32% | -28.02% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 175.97% | -62.40% | -31.01% | 17.32% | -28.02% |
|